TSX Venture Exchange Stock Maintenance Bulletins – QNT Press Release

[ad_1]

VANCOUVER, BC, April 11, 2022 /CNW/ –

TSX VENTURE COMPANIES

ELECTRA BATTERY MATERIALS CORPORATION (“ELBM”)
BULLETIN TYPE: Consolidation
BULLETIN DATE: April 11, 2022
TSX Venture Tier 2 Company

Pursuant to a resolution passed by shareholders on December 2, 2021the Company has consolidated its capital on an (18) eighteen old for (1) one new basis. The name of the Company has not been changed.

Effective at the opening on Wednesday, April 13, 2022the common shares of Electra Battery Materials Corporation will commence trading on TSX Venture Exchange on a consolidated basis. The Company is classified as a “Resource” company.

Post – Consolidation

Capitalization:

Unlimited

shares with no par value of which

31,245,233

shares are issued and outstanding

Escrow:

Nil

shares

Transfer Agent:

TSX Trust Company

Trading Symbol:

ELBM

(UNCHANGED)

CUSIP Number:

28474P201

(NEW)

________________________________________

LAHONTAN GOLD CORP. (“LG“)
BULLETIN TYPE: New Listing-Shares, Private Placement-Brokered
BULLETIN DATE: April 11, 2022
TSX Venture Tier 2 Company

New Listing-Shares

Effective at the opening Wednesday, April 13, 2022the shares of the Company will commence trading on TSX Venture Exchange. The Company is classified as a ‘Gold and Silver Ore Mining’ company.

The Company’s Listing Application dated March 28, 2022has been filed with and accepted by TSX Venture Exchange.

On April 6, 20221246765 BC Ltd. (“765 BC”), a non-listed reporting issuer, and Lahontan Gold Corp. (“Lahontan”), a private mining issuer, completed an arm’s length three-cornered amalgamation (the “Amalgamation”). Consideration for the Amalgamation consisted of the issuance of 82,660,501 Company shares on a 1 for 1 basis in exchange for common shares of 765 BC and Lahontan at a deemed price of $0.35 per share. 765 BC completed a share consolidation on a 2.7 old for 1 new basis in connection with the Amalgamation.

58,024,046 common shares issued to Principals pursuant to the Amalgamation are subject to a Tier 2 Value Security Escrow Agreement to be released over a 36-month period. In accordance with the Exchange’s Seed Share Resale Restrictions, 1,111,111 common shares issued to non-Principals are subject to a Tier 2 Value Security Escrow Agreement to be released over a 36-month period.

The Qualifying Property is located in Nevada, USA.

The Amalgamation also involved the following concurrent private placement transaction.

Private Placement-Brokered

TSX Venture Exchange has accepted for filing documentation with respect to a Brokered Private Placement of Lahontan subscription receipts announced March 16, 2022, March 24, 2022 and April 62022:

Number of Shares:

8,888,889 shares

Purchase Price:

$0.45 per share

Warrants:

4,444,444 share purchase warrants to purchase 4,444,444 shares

Warrant Exercise Price:

$0.65 for a one year period

$0.65 in the second year

Number of Places:

13 places

Insider / Pro Group Participation:

Insider=Y /

Name

ProGroup=P

# of Shares

Victoria Gold Corp.

Y

1,626,046

John McConnell

Y

108,000

Pro Group Involvement:
(1 placee)

P

125,000

Agent’s Fee:

Beacon Securities Limited received $43,008.45 cash and 95,574 warrants to purchase 95,574 shares, exercisable at $0.65 for 24 months.

Canaccord Genuity Corp. received $28,672.30 cash and 63,716 warrants to purchase 63,716 shares, exercisable at $0.65 for 24 months.

Corporate Jurisdiction:

British Columbia

Capitalization:

unlimited common shares with no par value of which
92,660,501 common shares are issued and outstanding

Escrowed Shares:

59,135,157 common shares

Transfer Agent:

TSX Trust Company

Trading Symbol:

LG (new)

CUSIP Number:

50732M 10 1 (new)

For further information, please refer to the Company’s Listing Application dated March 28, 2022.

Company Contact:

Kimberly Ann Arntson, President & CEO

Company Address:

217 Queen Street West, Suite 401

Toronto, ON M5V 0R2

Company Phone Number:

(530) 414-4400

Company Email Address:

kimberly.ann@lahontangoldcorp.com

__________________________________

NORONT RESOURCES LTD. (“NOT“)
BULLETIN TYPE: Property-Asset or Share Disposition Agreement, Remain Halted, Delist
BULLETIN DATE: April 11, 2022
TSX Venture Tier 1 Company

Effective at the close of business on Tuesday, April 12, 2022, the common shares of Noront Resources Ltd. (“Noront”) will be delisted from TSX Venture Exchange. The delisting of Noront shares results from the completion of a court-approved Plan of Arrangement under the Business Corporations Act (Ontario) (the “Arrangement”), pursuant to an Arrangement Agreement dated December 20, 2021among the Company and Wyloo Metals PTY LTD and Wyloo Canada Holdings PTY LTD (collectively, the “Buyers”), whereby the Buyers bought all issued and outstanding securities of the Company.

The Arrangement was approved by Noront’s shareholders on March 15, 2022 and approved by the Supreme Court of Ontario on April 1, 2022. Under the terms of the Agreement, each former shareholder of the Company, other than the Buyers, is entitled to receive a cash consideration of $1.10 per common share and all outstanding options immediately prior to the effective time of the Arrangement have been assigned to the Company and cancelled, without any further action of the holders thereof, in exchange for a cash payment equal to the in-the-money value of the options, less applicable with holdings.

For further details, please refer to Noront’s Management Information Circular dated February 11, 2022 and news releases dated December 22, 2022, February 3, 2022, March 15, 2022, March 28, 2022 and April 7, 2022.

________________________________________

THIOGENESIS THERAPEUTICS, CORP. (“TTI”)
[Formerly ROZDIL CAPITAL CORPORATION ("ROZ.P")]
BULLETIN TYPE: Qualifying Transaction-Completed/New Symbol, Private Placement-Non-Brokered, Name Change, Reinstated for Trading
BULLETIN DATE: April 11, 2022
TSX Venture Tier 2 Company

TSX Venture Exchange (the “Exchange”) has accepted for filing Rozdil Capital Corporation (the “Company”) Qualifying Transaction (“QT”) described in its Filing Statement dated March 17, 2022. As a result, on Wednesday, April 13, 2022the Company will no longer be considered a Capital Pool Company. The QT includes the following:

Pursuant to a securities exchange agreement dated February 8, 2021the Company has indirectly acquired all the outstanding securities of Thiogenesis Therapeutics, Inc. (“TTI-US”). The Company issued an aggregate of 12,771,075 common shares to the securityholders of TTI-US, excluding the common shares issued under the private placements below.

For further information, please refer to the Company’s Filing Statement dated March 17, 2022 and to the Company’s news release dated April 5, 2022.

Private Placement – ​​Non-Brokered

Prior to the completion of the QT, the Company completed a private placement of special warrants which have been exchanged into the following securities in the Resulting Issuer.

Number of Shares:

10,000,000 common shares

Purchase Price:

$0.35 per common share

Number of places:

68 places

Insider / Pro group participation:

Name

Insider=Y/
Pro Group=P

Number of Common
Shares

11 places

P

1,282,859

Finders’ Fees:

Arm’s length finders received $159,250 in cash and 455,0000 non-transferable compensation options to purchase 455,000 common shares at a price of $0.35 per share until July 29, 2022, subject to an acceleration clause.

The Company confirmed the closing of the Private Placement via a press release dated August 4, 2021.

Name Change

Following a special resolution approved by shareholders at a meeting held on September 3, 2021effective at the opening on Wednesday, April 13, 2022the common shares of the Resulting Issuer will commence trading on TSX Venture Exchange, and the common shares of Rozdil Capital Corporation will be delisted.

Post-Transactional
Capitalization:

Unlimited number of common shares with no par value of which27,910,175 common shares are issued and outstanding.

Escrow:

13,462,869 common shares (including 2,725,000 CPC escrowed shares) of which 1,346,287 common shares are released as at the date of this bulletin

Transfer Agent:

TSX Trust Company

Trading Symbol:

TTI (new)

CUSIP Number:

88410L102 (new)

The Resulting Issuer is classified as a “Research and development in the physical, engineering and life sciences” company (NAICS: 54171).

Reinstated for Trading

Effective at the opening on Wednesday, April 13, 2022, the shares of the Resulting Issuer will be reinstated for trading under the symbol “TTI”.

Company Contact:

Brook Riggins, Director

Company Address:

4 King Street West, Suite 401, Toronto, Ontario, M5H …

Full story available on Benzinga.com

[ad_2]

Source link